All Stories

  1. Should WHO-prequalified antigen-antibody fourth-generation rapid diagnostic tests be used to detect acute HIV infection? A systematic review and meta-analysis of diagnostic performance

    Article • March 2026, openRxiv

    Alani Sulaimon Akanmu

  2. Impact of Genital Chlamydia Trachomatis Infection in Women Presenting with Infertility in Lagos, Nigeria

    Article • Asian Journal of Research in Infectious Diseases, February 2025, Sciencedomain International

    Dr kehinde sharafadeen okunade, Alani Sulaimon Akanmu

  3. Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study

    Article • AIDS and Behavior, December 2024, Springer Science + Business Media

    Alani Sulaimon Akanmu

  4. High SARS-CoV-2 seroprevalence in Lagos, Nigeria with robust antibody and cellular immune responses

    Article • Journal of Clinical Virology Plus, August 2023, Elsevier

    Alani Sulaimon Akanmu

  5. Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study

    Article • Acta Cytologica, December 2022, Karger Publishers

    Dr kehinde sharafadeen okunade, Alani Sulaimon Akanmu

  6. The impact of dolutegravir‐based combination antiretroviral therapy on the spermatozoa and fertility parameters of men living with human immunodeficiency virus

    Article • Andrologia, October 2022, Wiley

    Alani Sulaimon Akanmu

  7. A Qualitative Study Exploring Factors Associated with Retention in HIV Care among Women with HIV in a Large HIV Clinic in Lagos, Nigeria, after Implementing the Test and Treat Policy

    Article • AIDS Research and Treatment, August 2022, Wiley

    Alani Sulaimon Akanmu

  8. Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion

    Article • PLOS One, June 2021, PLOS

    Alani Sulaimon Akanmu

  9. Frequency of beta S globin gene haplotypes among sickle cell patients in Nigeria

    Article • Journal of International Medical Research, June 2021, SAGE Publications

    Alani Sulaimon Akanmu

  10. Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria

    Article • Journal of Blood Medicine, May 2021, Taylor & Francis

    Dr kehinde sharafadeen okunade, Alani Sulaimon Akanmu

  11. Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria

    Article • European Journal of Clinical Pharmacology, March 2021, Springer Science + Business Media

    Alani Sulaimon Akanmu

  12. Effects of selenium supplementation on pregnancy outcomes and disease progression in HIV‐infected pregnant women in Lagos: A randomized controlled trial

    Article • International Journal of Gynecology & Obstetrics, January 2021, Wiley

    Adebola Adejimi, Dr kehinde sharafadeen okunade, Aloy Okechukwu Ugwu, Alani Sulaimon Akanmu

  13. Opportunistic fungal infections in persons living with advanced HIV disease in Lagos, Nigeria; a 12-year retrospective study

    Article • African Health Sciences, December 2020, African Journals Online (AJOL)

    Alani Sulaimon Akanmu

  14. Modeling cerebellar limb dysmetria and impaired spatial memory in rats using lamivudine: A preliminary study

    Article • Journal of Chemical Neuroanatomy, November 2020, Elsevier

    Alani Sulaimon Akanmu

  15. Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria

    Article • Journal of Pharmacological Sciences, November 2020, Elsevier

    Alani Sulaimon Akanmu

  16. Impact of the COVID-19 pandemic on global health research training and education

    Article • Journal of Global Health, September 2020, Edinburgh University Global Health Society

    Alani Sulaimon Akanmu

  17. Microscopic and biochemical changes on liver and kidney of Wistar rats on combination antiretroviral therapy: the impact of naringenin and quercetin

    Article • Toxicology Research, August 2020, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  18. The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation

    Article • PLOS One, August 2020, PLOS

    Alani Sulaimon Akanmu

  19. The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa

    Article • AIDS, August 2020, Wolters Kluwer Health

    Alani Sulaimon Akanmu

  20. Tackling cryptococcal meningitis in Nigeria, one-step at a time; the impact of training

    Article • PLOS One, July 2020, PLOS

    Rita Oladele, Alani Sulaimon Akanmu

  21. High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa

    Article • AIDS, May 2020, Wolters Kluwer Health

    Alani Sulaimon Akanmu

  22. A preprogram appraisal of factors influencing research productivity among faculty at college of medicine, University of Lagos

    Article • Annals of African Medicine, January 2020, Medknow

    Alani Sulaimon Akanmu

  23. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria

    Article • PLOS One, July 2019, PLOS

    Alani Sulaimon Akanmu

  24. Cryptococcal meningitis after ART: Need for proper baseline evaluation in the era of ‘Test & Treat’

    Article • Medical Mycology Case Reports, June 2019, Elsevier

    Alani Sulaimon Akanmu

  25. Safety and efficacy of rifabutin among HIV/TB-coinfected children on lopinavir/ritonavir-based ART

    Article • Journal of Antimicrobial Chemotherapy, May 2019, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  26. Plasma Biomarkers of Human Immunodeficiency Virus–Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy

    Article • The Journal of Infectious Diseases, May 2019, Oxford University Press (OUP)

    Prof Helen Carolyn Steel, Alani Sulaimon Akanmu

  27. First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda

    Article • AIDS Research and Therapy, January 2019, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu, Alani Sulaimon Akanmu

  28. CLINICALLY SIGNIFICANT DRUG-DRUG INTERACTION IN A LARGE ANTIRETROVIRAL TREATMENT CENTRE IN LAGOS, NIGERIA

    Article • Journal of Population Therapeutics and Clinical Pharmacology, January 2019, Codon Publications

    Alani Sulaimon Akanmu

  29. Effects of selenium supplementation on pregnancy outcome and disease progression in HIV-infected pregnant women in Lagos, Nigeria

    Article • Medicine, January 2019, Wolters Kluwer Health

    Dr kehinde sharafadeen okunade, Alani Sulaimon Akanmu

  30. Absence of human leukocyte antigen-B*57:01 amongst patients on antiretroviral therapy in Nigeria: Implications for use of abacavir

    Article • Nigerian Postgraduate Medical Journal, January 2019, Medknow

    Alani Sulaimon Akanmu

  31. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

    Article • The Lancet HIV, November 2018, Elsevier

    Alani Sulaimon Akanmu

  32. Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance

    Article • Scientific Reports, October 2018, Springer Science + Business Media

    Alani Sulaimon Akanmu

  33. Association between HIV-1 subtype and drug resistance in Nigerian infants

    Article • Journal of Antimicrobial Chemotherapy, September 2018, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  34. A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia

    Article • PLOS One, June 2018, PLOS

    Alani Sulaimon Akanmu

  35. A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals

    Article • PLoS Neglected Tropical Diseases, May 2018, PLOS

    Alani Sulaimon Akanmu

  36. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa

    Article • AIDS, May 2018, Wolters Kluwer Health

    Alani Sulaimon Akanmu

  37. Selenium deficiency and pregnancy outcome in pregnant women with HIV in Lagos, Nigeria

    Article • International Journal of Gynecology & Obstetrics, April 2018, Wiley

    Dr kehinde sharafadeen okunade, Alani Sulaimon Akanmu

  38. Correction to: Population data of 21 autosomal STR loci in the Hausa, Igbo and Yoruba people of Nigeria

    Article • International Journal of Legal Medicine, January 2018, Springer Science + Business Media

    Alani Sulaimon Akanmu

  39. When prevention of mother-to-child HIV transmission fails

    Article • AIDS, January 2018, Wolters Kluwer Health

    Alani Sulaimon Akanmu

  40. High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months: Results From a Nationwide Surveillance in Nigeria

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, January 2018, Wolters Kluwer Health

    Alani Sulaimon Akanmu

  41. Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program

    Article • AIDS Research and Therapy, October 2017, Springer Science + Business Media

    Alani Sulaimon Akanmu

  42. Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy

    Article • PLOS One, September 2017, PLOS

    Alani Sulaimon Akanmu

  43. Chronic pulmonary aspergillosis as a cause of smear-negative TB and/or TB treatment failure in Nigerians

    Article • The International Journal of Tuberculosis and Lung Disease, September 2017, International Union Against Tuberculosis and Lung Disease

    Alani Sulaimon Akanmu

  44. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts

    Article • Journal of the International AIDS Society, January 2017, Wiley

    Alani Sulaimon Akanmu

  45. Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis

    Article • Journal of Antimicrobial Chemotherapy, December 2016, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  46. Volume regulatory hormones and plasma volume in pregnant women with sickle cell disorder

    Article • Journal of the Renin-Angiotensin-Aldosterone System, September 2016, SAGE Publications

    DR Bosede B Afolabi, Alani Sulaimon Akanmu

  47. Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

    Article • The Journal of Infectious Diseases, July 2016, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  48. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa

    Article • Journal of Antimicrobial Chemotherapy, June 2016, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  49. Comparative periodontal status of human immunodeficiency virus-positive patients and controls in a dedicated human immunodeficiency virus clinic in Nigeria

    Article • Nigerian Journal of Clinical Practice, January 2016, Medknow

    Alani Sulaimon Akanmu

  50. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children

    Article • Journal of the International AIDS Society, January 2016, Wiley

    Alani Sulaimon Akanmu

  51. Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  52. Impact of HIV Infection and Zidovudine Therapy on RBC Parameters and Urine Methylmalonic Acid Levels

    Article • Interdisciplinary Perspectives on Infectious Diseases, January 2016, Hindawi Publishing Corporation

    Alani Sulaimon Akanmu

  53. Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa

    Article • Clinical Infectious Diseases, August 2015, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  54. Immunological and Virological Outcomes of Patients Switched from LPV/r to ATV/r-Containing Second- Line Regimens

    Article • Current HIV Research, May 2015, Bentham Science Publishers

    Alani Sulaimon Akanmu, Alani Sulaimon Akanmu

  55. Health related quality of life and perception of stigmatisation in adolescents living with sickle cell disease in Nigeria: A cross sectional study

    Article • Pediatric Blood & Cancer, March 2015, Wiley

    Dr titi a adeyemo, Alani Sulaimon Akanmu

  56. Prevalence of anti-A and anti-B hemolysis among blood group O donors in Lagos

    Article • Nigerian Journal of Clinical Practice, January 2015, Medknow

    Alani Sulaimon Akanmu

  57. Enhancement of Health Research Capacity in Nigeria Through North–South and In-Country Partnerships

    Article • Academic Medicine, August 2014, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  58. Prevalence and Determinants of Chronic periodontitis in HIV positive patients in Nigeria

    Article • Asian Pacific Journal of Tropical Disease, August 2014, Elsevier

    Alani Sulaimon Akanmu

  59. Potential drug–drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria

    Article • HIV/AIDS - Research and Palliative Care, April 2014, Taylor & Francis

    Professor Edamisan Olusoji Temiye, Alani Sulaimon Akanmu, Alani Sulaimon Akanmu

  60. Incidences of Hepatitis B and Syphilis Co-Infection with HIV in Antiretroviral Treatment-Naïve Adult Patients Attending APIN Clinic at a University Teaching Hospital in Lagos, Nigeria

    Article • Journal of AIDS & Clinical Research, January 2013, OMICS Publishing Group

    Alani Sulaimon Akanmu

  61. Prevalence and type of monoclonal gammopathy of undetermined significance in an apparently healthy Nigerian population: a cross sectional study

    Article • BMC Blood Disorders, June 2012, Springer Science + Business Media

    Alani Sulaimon Akanmu

  62. Identification and Characterization of Microsporidia from Fecal Samples of HIV-Positive Patients from Lagos, Nigeria

    Article • PLOS One, April 2012, PLOS

    Prof Wellington A Oyibo, Alani Sulaimon Akanmu

  63. Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria

    Article • BMC Research Notes, March 2012, Springer Science + Business Media

    Alani Sulaimon Akanmu

  64. Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria

    Article • Nigerian Journal of Clinical Practice, January 2012, Medknow

    Alani Sulaimon Akanmu

  65. Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital

    Article • HIV/AIDS - Research and Palliative Care, September 2011, Taylor & Francis

    Igwebuike Onyiaorah , Alani Sulaimon Akanmu

  66. Serum testosterone levels of HbSS (sickle cell disease) male subjects in Lagos, Nigeria

    Article • BMC Research Notes, August 2011, Springer Science + Business Media

    Alani Sulaimon Akanmu

  67. Blood transfusion requirements in cleft lip surgery

    Article • International Journal of Pediatric Otorhinolaryngology, May 2011, Elsevier

    Alani Sulaimon Akanmu

  68. Orofacial manifestation of hematological disorders: Hemato-oncologic and immuno-deficiency disorders

    Article • Indian Journal of Dental Research, January 2011, Medknow

    Alani Sulaimon Akanmu

  69. Orofacial manifestations of hematological disorders: Anemia and hemostatic disorders

    Article • Indian Journal of Dental Research, January 2011, Medknow

    Alani Sulaimon Akanmu

  70. Severe Presentation of Necrotizing Ulcerative Periodontitis in a Nigerian HIV-Positive Patient: A Case Report

    Article • Medical Principles and Practice, January 2011, Karger Publishers

    Alani Sulaimon Akanmu

  71. Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Pacific

    Article • International Journal of Epidemiology, November 2010, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  72. Suboptimal Etravirine Activity is Common During Failure of Nevirapine-Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1

    Article • Current HIV Research, April 2010, Bentham Science Publishers

    Alani Sulaimon Akanmu

  73. Frequency of homologous blood transfusion in patients undergoing cleft lip and palate surgery

    Article • Indian Journal of Plastic Surgery, January 2010, Thieme Publishing Group

    Alani Sulaimon Akanmu

  74. Clinical Evaluation of Extract of Cajanus cajan (Ciklavit®) in Sickle Cell Anaemia

    Article • Journal of Tropical Pediatrics, August 2005, Oxford University Press (OUP)

    Alani Sulaimon Akanmu

  75. Cytomegalovirus Antibodies Amongst Immunocompromised (HIV) Patients At Lagos University Teaching Hospital (LUTH) Idi - Araba, Lagos

    Article • Journal of Medicine, January 1970, Bangladesh Journals Online (BanglaJOL)

    Alani Sulaimon Akanmu